26 results on '"Miranda, Vasco"'
Search Results
2. #4713 TUMOR NECROSIS FACTOR RECEPTOR 2 POLYMORPHISM (RS1061622) AND INFLAMMATORY RESPONSE IN END-STAGE RENAL DISEASE PATIENTS UNDER DIALYSIS
3. MO810INTERLEUKIN-6 (-174G/C) POLYMORPHISM, RS1800795, IN ESRD PATIENTS' OUTCOME*
4. MO735INTERPLAY BETWEEN GDF-15 AND LEFT VENTRICULAR HYPERTROPHY IN END-STAGE RENAL DISEASE PATIENTS ON DIALYSIS
5. P1531DIURETIC USE IN HEMODIALYSIS PATIENTS: BENEFIC ASSOCIATION WITH RESIDUAL RENAL FUNCTION AND ALL-CAUSE MORTALITY
6. P1570INTERLEUKIN-6 (RS1800795) AND PENTRAXIN 3 (RS2305619) GENETIC POLYMORPHISMS AND THEIR RELATION WITH INFLAMMATION AND ALL-CAUSE MORTALITY IN ESRD PATIENTS ON DIALYSIS
7. P1263ASSOCIATION OF LEFT VENTRICULAR HYPERTROPHY AND ADIPOCYTOKINES IN PATIENTS ON DIALYSIS
8. P1581IMPACT OF ACHIEVING LDL CHOLESTEROL LOWER THAN 100 MG/DL WITH STATINS, ON LIPID PROFILE AND INFLAMMATION IN END-STAGE RENAL DISEASE PATIENTS
9. SP666MACHINE LEARNING IN PREDICTION OF VULNERABLE OR RESILIENT END-STAGE RENAL DISEASE PATIENTS
10. SP543ASSOCIATION OF PTX3, NT-proBNP AND LEFT VENTRICULAR HYPERTROPHY IN PATIENTS ON DIALYSIS
11. FP725PENTRAXIN 3 IN END-STAGE RENAL DISEASE: MULTIPLE RISK BIOMARKER AND PREDICTOR OF ALL-CAUSE MORTALITY
12. FP730EFFECTS OF STATINS THERAPY ON LDL SUBFRACTIONS AND INFLAMMATION, IN END-STAGE RENAL DISEASE PATIENTS ON DIALYSIS
13. SP674IN DIALYSIS PATIENTS FUROSEMIDE THERAPY IS FAVORABLY RELATED WITH INFLAMMATORY RESPONSE, FIBRINOLYSIS, AND BIOMARKERS OF RESIDUAL RENAL FUNCTION
14. SP637INFLAMMATION AND CELL-FREE DNA AS BIOMARKERS FOR THE OUTCOME OF END STAGE RENAL DISEASE PATIENTS
15. SP348ASSOCIATION OF NT-PRO-BNP WITH ANEMIA, INFLAMMATION AND KIDNEY FUNCTION IN PORTUGUESE DIALYSIS PATIENTS
16. SP665PENTRAXIN 3 VERSUS GROWTH DIFFERENTIATION FACTOR-15: ASSOCIATION WITH INFLAMMATION, IRON HOMEOSTASIS AND ERYTHROPOIESIS IN END-STAGE RENAL DISEASE PATIENTS
17. SP658INFLAMMATORY RESPONSE, FIBRINOLYSIS, AND BIOMARKERS OF RESIDUAL KIDNEY FUNCTION IN HEMODIALYSIS PATIENTS: RELATIONSHIP WITH FUROSEMIDE THERAPY
18. SP656ENDOTHELIAL (DYS)FUNCTION IN PORTUGUESE END-STAGE RENAL DISEASE PATIENTS ON HEMODIALYSIS
19. SP342HEPCIDIN-25 AND TREATMENT WITH ERYTHROPOIESIS STIMULATING AGENTS ARE INDEPENDENTLY RELATED WITH ERYTHROPOIESIS IN CHRONIC HEMODIALYSIS PATIENTS
20. SP651ANXIETY AND DEPRESSION IN END STAGE RENAL DISEASE PATIENTS AND ITS ASSOCIATION WITH CLINICAL AND LABORATORIAL DATA
21. MP723PREVALENCE AND DETERMINANTS OF FRAILTY IN END STAGE RENAL DISEASE UNDER ONLINE HEMODIAFILTRATION
22. MP759BEING HERE IS A PRISON: PATIENT REPORTED QUALITY OF LIFE BURDENS ASSOCIATED TO DIALYSIS
23. MP585PREVALENCE OF DEPRESSIVE SYMPTOMS IN END STAGE KIDNEY DISEASE PATIENTS UNDER DIALYSIS AND ITS ASSOCIATION WITH SOCIODEMOGRAPHIC AND CLINICAL DATA
24. MP600SELF REPORTED END STAGE RENAL DISEASE ADHERENCE QUESTIONNAIRE AND ITS ASSOCIATION WITH POTENTIAL BIOMARKERS OF NON ADHERENCE
25. MP664PREVALENCE OF FRAILTY AND ITS ASSOCIATION WITH QUALITY OF LIFE, CLINICAL AND BIOCHEMICAL MARKERS IN END-STAGE RENAL DISEASE PATIENTS UNDER DIALYSIS
26. MP674POLYMORPHISMS OF THE ELANE GENE PROMOTER REGION IN END-STAGE CHRONIC KIDNEY DISEASE PATIENTS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.